Detalhe da pesquisa
1.
Ovarian function recovery in breast cancer patients receiving adjuvant anastrozole treatment: updated results from the phase 3 DATA trial.
Breast Cancer Res Treat;
2024 Jun 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38940981
2.
Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG).
Oncologist;
28(10): e877-e883, 2023 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37310797
3.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat;
180(3): 675-685, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32124136
4.
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer.
Acta Oncol;
59(6): 713-722, 2020 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32141389
5.
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
Int J Cancer;
145(5): 1325-1333, 2019 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30748011
6.
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Int J Cancer;
145(1): 274-283, 2019 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30588619
7.
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol;
19(12): 1630-1640, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30413379
8.
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).
Breast Cancer Res Treat;
172(2): 413-423, 2018 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30121808
9.
Single-nucleotide polymorphisms in the genes of CES2, CDA and enzymatic activity of CDA for prediction of the efficacy of capecitabine-containing chemotherapy in patients with metastatic breast cancer.
Pharmacol Res;
128: 122-129, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28827188
10.
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
Lancet Oncol;
18(11): 1502-1511, 2017 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29031778
11.
Genotypes of CYP2C8 and FGD4 and their association with peripheral neuropathy or early dose reduction in paclitaxel-treated breast cancer patients.
Br J Cancer;
115(11): 1335-1342, 2016 Nov 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27736846
12.
Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch Colorectal Cancer Group.
Lancet;
385(9980): 1843-52, 2015 May 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25862517
13.
Patients' Preferences for Information About the Benefits and Risks of Second-Line Palliative Chemotherapy and Their Oncologist's Awareness of These Preferences.
J Cancer Educ;
31(3): 443-8, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25985960
14.
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial.
Lancet Oncol;
15(9): 943-53, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25035291
15.
Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial.
EClinicalMedicine;
58: 101901, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36992863
16.
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
JNCI Cancer Spectr;
7(6)2023 10 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37991939
17.
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial.
NPJ Breast Cancer;
9(1): 75, 2023 Sep 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37689749
18.
Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial.
JAMA Oncol;
7(7): 978-984, 2021 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34014249
19.
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
J Hematol Oncol;
14(1): 64, 2021 04 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33865430
20.
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5-13/TESARO PR-30-50-10-C BRAVO Study.
Clin Cancer Res;
27(20): 5482-5491, 2021 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34301749